Portfolio

Though Cyma specializes in the Life Science and Pharmaceutical sectors, our technical capabilities have proven to be a valuable commodity across a variety of industries. Cyma’s partnerships include Corporate, Healthcare and University clients, with whom we seek to establish long standing relationships and track record of success. The projects listed below showcase a representative sample of the diverse applications constituting Cyma’s annual portfolio.

Renaissance – Spray Lab

For this project, we transformed a warehouse into a state-of-the-art dynamic laboratory space, complete with new lab areas, mechanical mezzanines, and upgraded utilities. The project encompassed diverse construction and renovation tasks to meet the client’s requirements. Central to the transformation was the creation of new lab spaces, including supporting facilities like restrooms and a loading […]

Cyma Completes Phase 2 of August Bio Expansion

Cyma Builders proudly announces the successful completion of Phase 2 at August Bioservices, marking a milestone in our commitment to construction excellence and client satisfaction. Expanding GMP Production Spaces and cGMP Warehouse Capacity The primary objective of Phase 2 was to augment the existing GMP production spaces and cGMP warehouse capacity at the facility. This […]

Almac Groundbreaking Ceremony

Cyma Builders, Almac, & the design partners gathered to celebrate the groundbreaking of the Almac North American Headquarters Expansion Project (Souderton, PA). This transformative initiative will enhance the existing campus by adding an impressive 113,410 square feet, increasing parking capacity, and implementing substantial site and utility infrastructure improvements. Read Almac’s announcement of the ceremony here.

August Bio Fill Suite Renovation

Cyma Builders completely renovated an exi sting pharmaceutical production space for August Bioservices, helping to facilitate their future business goals.

GMP Production Suites for Confidential Client

Cyma Builders successfully completed the GMP production suites for one of our confidential clients! We are proud to share that our team was not only able to accomplish the expansion successfully, but also overcome the project’s unique challenges in a seamless way.

Cyma Builders Completes Charles River Projects

Cyma Builders recently completed a portfolio of projects for Charles River across their Malvern & Wayne Facilities. The portfolio consisted of a variety of laboratory, clean room and infrastructure upgrades across the two facilities. Click here to check out more details on the ISO 6 clean room!

Charles River A36 Clean Room

Cyma Builders and Construction Managers completed a 3,800 SF cleanroom ﬁt-out in Malvern, PA, on behalf of Charles River Labs. The project was started on November 2, 2020, during the height of the COVID pandemic and completed on March 22,2021. The ﬁt-out of the suite included three ISO 6 main production suites with multiple ISO […]

Cyma Builders Completes Central Utility Plant Expansion

Cyma Builders was contracted to build an expansion to an existing Central Utility Plant in Jacksonville, FL. Not only did this project present technical challenges based on the complexity of the MEP systems and controls being implemented, but the COVID-19 pandemic created manpower, shipping, and fabrication issues that contributed to difficulties faced in completing this […]

Cyma Builders Completes Major Fit Out of New Office and Testing Building

Cyma Builders and Construction Managers is pleased to announce the successful completion of a major fit out project located at a new office and testing building in the Philadelphia Navy Yard. The project was started on July 22nd, 2020 during the height of the COVID pandemic and was approached in two phases. The first phase […]

Confidential – CAR-T R&D Laboratory

Cyma Builders and Construction Managers was retained by a confidential client to construct a new 12,000 SF R&D laboratory. The lab was designed to be in compliance with current BSL 2 and BSL 2+ biosafety levels to support current and future cell therapy initiatives. As a part of […]